Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate to determine the effect of food on the PK of a single dose of 600 mg Volitinib and its two major metabolites in healthy subjects.


Clinical Trial Description

The purpose of this study is to evaluate to determine the effect of food on the PK( pharmacokinetics) of a single dose of 600 mg Volitinib and its two major metabolites in healthy subjects and to assess the safety and tolerability of single doses of 600mg in healthy subjects.This study will be an open-label, randomized, four-period, crossover PK food effect study of Volitinib administered orally at 600 mg. Subjects will be screened for eligibility up to 14 days prior to entry into the study,there will be 4 treatments,2 weeks follow-up. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02017236
Study type Interventional
Source Hutchison Medipharma Limited
Contact
Status Completed
Phase Phase 1
Start date November 2013
Completion date June 2014

See also
  Status Clinical Trial Phase
Completed NCT04501640 - A Study to Investigate the Effect of Food With Mirabegron in Healthy Chinese Participants Phase 4
Completed NCT01224587 - Magnetic Marker Monitoring (MMM) Study With Gel Matrix Tablets Under Fasting and Fed Conditions Phase 1
Withdrawn NCT02560363 - A Study to Compare the Pharmacokinetics of Different Formulations of AZD9977 and the Influence of Food in Healthy Male Subjects Phase 1
Completed NCT03150498 - A Food Effects Study and Optional Multi Dose Study to Assess PK of BTD-001 Phase 1
Completed NCT01686217 - A Phase I Study to Compare 3 Different Strengths of an Extended Release Formulation of ASP015K to an Immediate Release Formulation of ASP015K Phase 1
Completed NCT01322464 - Study to Assess Food Effect on Sativex Bioavailability Phase 1
Completed NCT03885778 - A Food Effect Study of Besifovir in Healthy Subjects Phase 4
Completed NCT05690932 - A Formulation Bridging and Food Effect Study of PBI-200 in Healthy Volunteers Phase 1
Completed NCT05187169 - Food Effect of VS-6766 in Healthy Adult Subjects Phase 1
Completed NCT05217732 - Study to Assess the Safety, Tolerability and Pharmacokinetics of ZX-7101A and the Food Effect in Healthy Volunteers Phase 1